- Open Access
Diagnosis and treatment of carotid body paraganglioma: 21 years of experience at a clinical center of Serbia
World Journal of Surgical Oncology volume 3, Article number: 10 (2005)
The carotid body paraganglioma (chemodectoma) is a relatively rare neoplasm of obscure origin. These are usually benign and commonly present as asymptomatic cervical mass.
Patients and methods
Records of 12 patients (9 female and 3 male) with carotid body tumors treated between 1982 and 2003, treated at our center were retrospectively reviewed. Data on classification, clinical presentation, and surgical treatment were extracted from the case records. Surgical complications and treatment outcome were noted and survival was calculated by actuarial method. The literature on carotid body paraganglioma was reviewed.
The average age of the patients was 52 years (range 30–78 years). Eight of these cases presented as a large asymptomatic non-tender neck mass, and two each presented with dysphagia, and hoarseness of voice. As per Shamblin classification seven of tumors were type II and 5 were types III. In 7 cases subadventitial tumor excision was performed, while in 5 associated resection of both external and internal carotid arteries was carried out. The artery was repaired by end-to-end anastomosis in one case, with Dacron graft in one case, and with saphenous vein graft in 3 cases. There was no operative mortality. After a mean follow-up of 6.2 years (range 6 months to 20 years), there were no signs of tumor recurrence in any of the cases.
Surgical excision is the treatment of choice for carotid body paragangliomas although radiation therapy is an option for patients who are not ideal candidates for surgery. For the tumors that are in intimate contact with carotid arteries, the treatment by vascular surgeon is recommended.
Paraganglioma arising from the carotid body are relatively rare tumors but constitute majority of head and neck paragangliomas (60–70%) [1–6]. The term paraganglia was first used by Kohn in the early twentieth century and is the most appropriate nomenclature from an embryologic standpoint [3–5]. Other terms such as carotid body tumor, glomus tumor, chemodectomas, and nonchromaffin tumor are less accurate terms and therefore should be best avoided [7–13]. The neoplasm present as asymptomatic neck mass. We report our experience with surgically treated carotid body tumors.
Patients and methods
Between 1982 and 2003, 12 patients (9 female and 3 male) with carotid body paraganglioma were surgically treated at the Institute for Cardiovascular Diseases, Serbian Clinical Centre. Mean age of the patients was 52 years (range 30–78 years). The records of these patients were retrospectively reviewed for clinical presentation, diagnostic work-up, surgical treatment, and outcome. Descriptive data was presented as frequency and percentage. Survival was calculated by actuarial method. World literature on carotid body paraganglioma was reviewed. The articles were extracted using the key words carotid body and paraganglioma.
All the patients were followed-up periodically every 6 months for the first year, yearly for next 5 years, thereafter only select patients were followed. The patients who had undergone carotid artery repair were followed-up with yearly duplex scanning; two patients were followed by a computerized tomography (CT) scan, and one by regular magnetic resonance (MR) imaging.
Eight cases presented as large non-tender neck masses located just anterior to the sternocleidomastoid muscle, two patients presented with dysphagia due to hypoglossal nerve compression, while two other had hoarseness of voice. The duplex ultrasonography and selective carotid angiography were used for diagnosis in the eleven cases, CT in five, and MR imaging in three cases (Figure 1 and 2). In one case the diagnosis was established on intraoperative exploration.
Intraoperatively on exploration of the neck seven of the cases showed a medium size tumor intimately associated and compressing carotid vessels (Shamblin II), and a large tumor involving carotid vessels in five cases (Shamblin III). In 7 cases of Shamblin II carotid body paraganglioma a subadventitial tumor excision was performed while in other 5 cases both external and internal carotid arteries were resected. One of these was repaired by end-to-end anastomosis, one with interposition of Dacron® graft, and other 3 were repaired with reversed saphenous vein graft.
The histological examination showed no signs of malignancy in any of the tumors. In two cases transient hypoglossal nerve palsy was noticed. Another patient had unexpected postoperative hoarseness of voice due to the transient vagus nerve palsy. All these three cases subsequently recovered. There was no operative mortality. The patients were followed-up from the 6 months to 20 years (mean 6.2 year) no local, regional or distant metastasis was noticed. The actuarial survival was 100%.
The carotid body was first described by von Haller in 1743 . It is highly specialized organ located at the common carotid artery bifurcation. Its feeding vessels run primarily from the external carotid artery. The function of the carotid body is related to autonomic control of the respiratory and cardiovascular systems, as well as blood temperature [3, 10, 12, 15–23]. Paraganglioma is a relatively rare neoplasm occurring in carotid body [1–6].
The carotid body paraganglioma is more common in women [2–5, 20, 25–28]. The incidence of bilateral carotid body lesions is approximately 10%. Most of these lesions are benign however malignant behavior is often encountered. For diagnosis of malignant carotid body paraganlioma there are no clear histological characteristics that differentiate it from benign lesions. This diagnosis is reserved for the tumors with local, regional and distant metastasis. The rate of malignancy is reported to be 6–12.5% of all cases [3–5, 9, 11, 29–35]. The 7–9% of the cases are hereditary [2, 4, 20, 25–28, 36]. None of our cases were bilateral or hereditary.
Carotid body paraganglioma often present as slow growing, non-tender neck masses located just anterior to the sternocleidomastoid muscle at the level of the hyoid. The tumor is mobile in the lateral plane but its mobility is limited in the cephalocaudal direction [3–5, 13–15, 21, 26, 36–38]. Occasionally the tumor mass may transmit the carotid pulse or demonstrate a bruit or thrill . Because of its location in close approximation to carotid vessels and X-XII cranial nerves, tumors enlargement causes progressive symptoms such as dysphagia (two of our cases), odynophagia, hoarseness of voice (two of our cases) or other cranial nerve deficits [2–5, 14, 26, 27, 32, 37, 40]. The patients may give a history suggestive of symptoms associated with catecholamine production such as fluctuating hypertension, blushing, obstructive sleep apnea and palpitations [3–5, 10, 14, 15, 21–23, 37].
Size of the tumor has a great importance not only for its clinical manifestations but also for treatment. In 1971, Shamblin introduced a classification system based on tumors size . They classified small tumors that could be easily dissected away from the vessels as group I. Group II (7 of our cases) included paragangliomas of medium size that were intimately associated and compressed carotid vessels, but could be separated with careful subadventitial dissection. Group III consisted of (5 of our cases) tumors that were large and typically encased the carotid artery requiring partial or complete vessel resection and replacement. Histologically, carotid body paraganglioma resemble the normal architecture of the carotid body. The tumors are highly vascular, and between the many capillaries are clusters of cells called Zellballen .
The carotid angiography is the most useful diagnostic test for paragangliomas. The angiography demonstrates tumor blood supply and widening of the carotid bifurcation by a well-defined tumor blush ("lyre sign"), which is classic pathognomonic angiographic finding [5, 8, 37–39, 42, 43]. MR and contrast CT are more effective non-invasive imagining modalities comparing with duplex ultrasonography, especially for small tumors [3, 37–39, 42–45]. Radioimmunodetection of carotid body paraganglioma by 111In labeled anti-CEA antibody is also described in literature [9, 46]. The differential diagnosis includes other tumors in this area, carotid artery aneurysms and elongation. For this reason using of precutaneous fine-needle aspiration for preoperative diagnosis of carotid body paraganglioma, can be very dangerous .
Resection of carotid body paraganglioma carries inherent risks of injury to the cranial nerves, carotid arteries as well excessive blood loss. Reigner first attempted resection of a carotid body paraganglioma in 1880, but the patients did not survive . Maydel was the first to remove a carotid body paraganglioma successfully in 1886, but the patient became aphasic and hemiplegics due to internal carotid artery ligature . In 1903, Scudder performed the first successful removal of carotid body paraganglioma . The surgical excision with careful subadventitial dissection is treatment of choice for most carotid body paragangliomas (Shamblin I and II) [2–6, 14–18, 34, 37–40, 43]. The Shamblin III of carotid body paraganglioma requires resection of the external and/or internal carotid artery. If the internal carotid is encased in tumor or damaged during resection, immediate repair/replacement should be performed [15, 37, 39, 40, 42, 43, 51, 52]. The second problem during tumor excision is bleeding, which sometimes can be massive. In such cases clamping of all carotid arteries is useful, with placement of internal carotid shunt [18, 35, 37]. Having in mind our experience with surgical treatment of both carotid body gangliomas as well as carotid stenosis, we recommend Pruitt-Inahara double balloon occlusive internal carotid shunt . The placement of this shunt through incision on the common carotid artery contributes to the adequate bleeding control from the common and internal carotid arteries, as well as brain protection. This procedure gave a clean and dry operative field during tumor removal [3, 37]. Some other articles recommend angiographic embolization preoperatively [3, 23, 37, 42, 53–55]. The Preoperative embolization of a carotid body paraganglioma can be performed by ethanol or polyvinyl alcohol. The finally result is a complete devascularization . Earlier the carotid body paragangliomas were considered radioresistant . However, more recent studies indicate good responses to radiation therapy [11, 30]. Most authors recommend radiotherapy for giant and recurrent carotid body paragangliomas, and with malignant carotid body paragangliomas metastatic to the regional lymph nodes [8, 33–36].
The modern surgical techniques have reduced the risk of postoperative stroke in carotid body paraganglioma resection to less than 5% [37, 40, 56]. However, the incidence of cranial nerve injury remains strikingly high, ranging from 20% to 40% [37, 38, 48, 56, 57]. In 20% of patients the neurological deficits is permanent. We found two (18%) transient hypoglossal, and one transient vagus nerve damage. recurrence after complete resection occurs in approximately 6% of patients [15, 37, 39, 40, 42, 43, 51, 52]. In our study however, there were no recurrences. The patients with internal carotid artery reconstruction should undergo duplex scanning periodically to identify graft stenosis.
Early operative management is warranted to avoid the possibility of eventual metastasis and progressive local invasion to the point of inoperability. In case of tumors intimately contact with carotid arteries, the treatment by vascular surgeon is recommended.
Sykes JM, Ossoff RH: Paragangliomas of the Head and Neck. Otolaryngol Clin North Am. 1986, 19: 755-767.
Sobol SM, Dailey JC: Familial multiple cervical paragangliomas: report of a kindred and review of the literature. Otolaryngol Head Neck Surg. 1990, 102: 382-390.
Myers EN, Johnson JT: Neoplasms. Otolaryngology-Head and Neck Surgery. Edited by: Cummings, CW, Fredrickson JM, Harker LA, Krause CJ, Schuller DE. 1993, St Louis; Mosby Year Book, 1590-1597.
Kyriakos M: Pathology of selected soft tissue tumors of the head and neck. Comprehensive Management of Head and Neck Tumors. Edited by: Thawley SE, Panje WR. 1987, Philadelphia PA. W.B. Saunders, 1261-1264.
Maves MD: Vascular tumors of the head and neck. Head and Neck Surgery-Otolaryngology. Edited by: Bailey BJ, Johnson JT, Kohut RI, Pillsbury HC, Tardy ME. 1993, Philadelphia JB Lippincott, 1397-1409.
Rush Bf: Current concepts in the treatment of carotid body tumors. Surgery. 1962, 52: 679-
Balatsouras DG, Eliopoulos PN, Economou CN: Multiple glomus tumors. J Laryngol Otol. 1992, 106: 538-543.
Mayer R, Fruhwirth J, Beham A, Groell R, Poschauko J, Hackl A: Radiotherapy as adjunct to surgery for malignant carotid body paragangliomas presenting with lymph node metastases. Strahlenther Onkol. 2000, 176: 356-360.
Pacheco-Ojeda L: Malignant carotid body tumors: report of three cases. Ann Otol Rhinol Laryngol. 2001, 110: 36-40.
Kairemo KJA, Hopsu EVM: Radioimmunodetection of Chemodectoma by In-111 labeled anti-CEA antibody. Clin Nucl Med. 1990, 15: 900-903.
Saldana MJ, Salem LE, Travezan R: High altitude hypoxia and chemodectomas. Hum Pathol. 1973, 4: 251-263.
Heath D: The human carotid body in health and disease. Journal of Pathology. 1991, 164: 1-8.
Dickinson AM, Trauer CA: Carotid body tumors: Review of the literature with the report of two cases. Am J Surg. 1945, 60: 9-10.1016/S0002-9610(45)90344-8.
Milewski C: Morphology and clinical aspects of paragangliomas in the area of head-neck. HNO. 1993, 41: 526-531.
Boyd JD: The development of human carotid body contributions to embryology. Surgery. 1937, 152: 1-
Gordon-Taylor G: On carotid tumors. Br J Surg. 1990, 28: 163-172.
Anderson R, Scarcella JV: Carotid body tumors. Am J Surg. 1963, 106: 856-859.
Eyzaguirre C: Neurobiology and Cell Physiology of Chemoreception. 1993, New York: Plenum Press, 123-129.
McCaffrey TV, Meyer FB, Michels VV, Piepgras DG, Marion MS: Familial Paragangliomas of the head and neck. Arch Otol Head Neck Surg. 1994, 120: 1211-1216.
Boyle JR, London NJ, Tan SG, Thurston H, Bell PR: Labile blood pressure after bilateral carotid body tumor surgery. Eur J Vasc Endovasc Surg. 1995, 9: 346-348.
Metersky ML, Castriotta RJ, Elnaggar A: Obstructive sleep apnea due to a carotid body paraganglioma. Sleep. 1995, 18: 53-54.
Roncorony AJ, Montiel GC, Soweniac GB: Bilateral carotid body paraganglioma and central alveolar hypoventilation. Respiration. 1993, 60: 243-246.
Shedd DP, Arias JD, Glunk RP: Familial occurrence of carotid body tumors. Head and Neck. 1990, 12: 496-499.
Rush BF: Familial bilateral carotid body tumors. Ann Surg. 1963, 157: 633-636.
Ridge BA, Brewster DC, Darling RC, Cambria RP, LaMuraglia GM, Abbott WM: Familial carotid body tumors: incidence and implications. Ann Vasc Surg. 1993, 7: 190-194.
Katz AD: Carotid body tumors in a large family group. Am J Surg. 1964, 108: 570-573. 10.1016/0002-9610(64)90157-6.
Strauss M, Nicholas GG, Abt AB, Harrison TS, Seaton JF: Malignant catecholamine-secreting carotid body paraganglioma. Otolaryngol Head Neck Surg. 1983, 91: 315-321.
Valdagni R, Amichetti M: Radiation therapy of carotid body tumors. Am J Clin Oncol. 1990, 13: 45-48.
Fanning JR, Woods FM, Christian HJ: Metastatic carotid body tumor. Report of the case with the review of the literature. JAMA. 1963, 185: 49-
Voorda AL, Jacobson N, Anttmen J: Slowly growing pulmonary metastases of malignant cervical chemodectoma. Acta Oncol. 1994, 33: 77-78.
Morris GC, Balas PE, Cooley DA, Crawford ES, Debakey ME: Surgical treatment of benign and malignant carotid body tumors: clinical experience with sixteen tumors in twelve patients. Am Surg. 1963, 29: 429-437.
Patetsios P, Gable DR, Garrett WV, Lamont JP, Kuhn JA, Shutze WP, Kourlis H, Grimsley B, Pearl GJ, Smith BL, Talkington CM, Thompson JE: Management of carotid body paragangliomas and review of a 30-year experience. Ann Vasc Surg. 2002, 16: 331-338. 10.1007/s10016-001-0106-8.
Zabel A, Milker-Zabel S, Huber P, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J: Fractionated stereotactic conformal radiotherapy in the management of large chemodectomas of the skull base. Int J Radiat Oncol Biol Phys. 2004, 58: 1445-1450. 10.1016/j.ijrobp.2003.09.070.
Elshaikh MA, Mahmoud-Ahmed AS, Kinney SE, Wood BG, Lee JH, Barnett GH, Suh JH: Recurrent head and-neck chemodectomas: a comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys. 2002, 52: 953-956. 10.1016/S0360-3016(01)02751-1.
Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Antonelli PJ, Cassisi NJ: Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale. Head Neck. 2001, 23: 363-371. 10.1002/hed.1045.
Evenson LJ, Mendenhall WM, Parsons JT, Cassisi NJ: Radiotherapy in the management of chemodectomas of the carotid body and glomus vagale. Head Neck. 1998, 20: 609-613. 10.1002/(SICI)1097-0347(199810)20:7<609::AID-HED5>3.0.CO;2-8.
Defraigne JO, Sakalihassan N, Antoine P, Thiry A, Limet R: Carotid chemodectomas. Experience with nine cases with reference to preoperative embolization and malignancy. Acta Chir Belg. 1997, 97: 220-228.
Por YC, Lim DT, Teoh MK, Soo KC: Surgical management and outcome of carotid body tumours. Ann Acad Med Singapore. 2002, 31: 141-144.
Mall J, Saclarides T, Doolas A, Eibl-Eibestfeld B: First report of hepatic lobotomy for metastatic carotid body tumor. J Cardiovas Surg. 2000, 41: 759-761.
Pandey M, Chandramohan K, Sebastian P, Ramachandran K: An unusual bilateral cervical paraganglioma: a case report. Int J Oral Maxillofac Surg. 2002, 31: 335-337. 10.1054/ijom.2001.0196.
Lotina S, Davidoviæ L, Havelka M, Vojnoviæ B, Neškoviæ V, Petar Stojanov, Kecman N: Carotid body tumors. J Serbian Med Soc. 1997, 125: 278-284.
Johnson JT: Parapharyngeal space masses: diagnosis and management. Otolaryngology. Edited by: Paparella, MM, Shumrick DA, Gluckman JL, Meyerhoff WL. 1991, Philadelphia, W B Saunders, 2584-2585.
Laube HR, Fahrenkamp AG, Backer W, Scheld HH: Glomus tumors: A diagnostic and surgical challenge?. J Cardiol. 1994, 83: 373-380.
Javid H, Dye WS, Hunter JA, Najafi H, Julian OC: Surgical management of carotid body tumor. Arch Surg. 1967, 95: 771-779.
Shamblin WR, ReMine WH, Sheps SG, Harrison EG: Carotid body tumor (chemodectoma): Clinicopathologic analysis of ninety cases. Am J Surg. 1971, 122: 732-739. 10.1016/0002-9610(71)90436-3.
Devuyever D, Mathurin P, Dooms G, Hamoir M: Lateral neck paraganglioma: diagnostic imaging and preoperative embolization. J Belge Radiol. 1993, 76: 15-19.
Matticari S, Credi G, Pratesi C, Bertin D: Diagnosis and surgical treatment of the carotid body tumors. J Cardiovasc Surg. 1995, 36: 233-239.
Miselli A, Bresciani P, Soana G, Bianchi E, Cocchi S, Marchini L: Carotid glomus tumors. Study of 2 cases using color Duplex ulstrasonography. Radiol Med (Torino). 1994, 88: 877-880.
Carriero A, Tonni AG, D'Ettorre L, Iezzi A, Tartaro A, Bonomo L: Neoplasms of the glomus caroticum: magnetic resonance angiography versus magnetic resonance. Radiol Med (Torino). 1994, 87: 71-75.
Kwekkeboom DJ, van Urk H, Pauw BK, Lamberts SW, Kooij PP, Hoogma RP, Krenning EP: Osteroid scintigraphy for detection of paragangliomas. J Nucl Med. 1993, 34: 873-878.
Fleming MV, Oertel YC, Rodriguez ER, Fidler WJ: Fine-needle aspiration of 6 carotid body paragangliomas. Diagn Cytopath. 1993, 9: 510-515.
Lahey FA, Warren KW: A long term appraisal of carotid body tumors with remarks on their removal. Surg Gynecol Obstet. 1951, 92: 481-491.
Byrned JJ: Carotid body and allied tumors. Am J Surg. 1958, 95: 371-384. 10.1016/0002-9610(58)90537-3.
Scudder CL: Tumor of the intercarotid body. A report of one case, together with all cases in literature. Am J Med Sci. 1903, 126: 1384-
Anand VK, Alemar GO, Sanders TS: Management of the internal carotid artery during carotid body tumor surgery. Laryngoscope. 1995, 105: 231-235.
Rabl H, Friehs I, Gutschi S, Pascher O, Koch G: Diagnosis and treatment of carotid body tumors. Thorac Cardiovasc Surg. 1993, 41: 340-343.
Eskridge JM, Harris AB, Finch L, Altois MA: Carotis synus syndrome and embolization procedures. Am J Neuroradiol. 1993, 14: 818-820.
Higo R, Asai M, Sugasawa M, Takeuchi N, Nemoto S: Preoperative embolization for paraganglioma. Aurits Nasus Larynx. 1994, 21: 122-125.
Horowitz M, Whaismant RE, Jungreis C, Syderman C, Levy EI, Kassam A: Temporary balloon occlusion and ethanol injection for preoperative embolization of carotid-body tumor. Ear Nose Throat J. 2002, 81: 536-538.
Hallett JW, Nora JD, Hollier LH, Cherry KJ, Pairolero PC: Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: A 50-year experience with 153 tumors. J Vasc Surg. 1988, 7: 284-291. 10.1067/mva.1988.avs0070284.
Wang SJ, Wang MB, Barauskas TM, Calcaterra TC: Surgical management of Carotid body tumors. Otorynogol Head Neck Surg. 2000, 123: 202-206. 10.1067/mhn.2000.106709.
The author(s) declare that they have no competing interests.
LBD: Preperation of draft manuscript
VBD: Literature search, data collection
DMV: Study design, data analysis, interpretation, preparation of draft
RPS: Study coordination, data interpretation, manuscript preperation
SND: Manuscript editing, preparation of final manuscript for publication
All authors read and approved the manuscript.
About this article
Cite this article
Davidovic, L.B., Djukic, V.B., Vasic, D.M. et al. Diagnosis and treatment of carotid body paraganglioma: 21 years of experience at a clinical center of Serbia. World J Surg Onc 3, 10 (2005) doi:10.1186/1477-7819-3-10
- Carotid Artery
- Obstructive Sleep Apnea
- Internal Carotid Artery
- Carotid Body